PHARMACOLOGICAL KINDLING

药理点燃

基本信息

  • 批准号:
    3845320
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

The objectives of this project are to study and manipulate the course of development of pharmacologically kindled seizures using the local anesthetics lidocaine and cocaine. In addition to seizures, other behavioral abnormalities are studied, including behavioral stereotypies with cocaine, aggression with lidocaine, and mortality related to cocaine seizures. The kindling effects of cocaine are likely related to its local anesthetic properties, as similar effects are seen with lidocaine but not with other psychomotor stimulants. The importance of local anesthetic mechanisms in human cocaine abuse remains to be determined, but aspects of cocaine-related panic disorder (which is reported by 50% of cocaine users calling a cocaine hotline) resemble kindled seizure development and thus provide an intriguing clinical-basic research overlap. significant findings of this project include the demonstration that 1) the development of local anesthetic kindled seizures and their associated lethality can be prevented with chronic, but not acute or repeated acute, carbamazepine treatment; 2) the local anesthetic kindled seizure model may offer a novel approach to examining carbamazepine's mechanisms of action in affective illness, which also requires chronic treatment; 3) the following systems have been ruled out as being necessary to carbamazepine's anticonvulsant effects in this seizure model: alpha-2-adrenergic receptors, peripheral-type benzodiazepine receptors, serotonin and somatostatin; 4) the stress related peptide corticotropin releasing hormone (CRH) and the tricyclic antidepressant desmethylimipramine (DMI) potentiate cocaine kindled seizure development.
这个项目的目的是研究和操纵的过程

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

S R WEISS其他文献

S R WEISS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('S R WEISS', 18)}}的其他基金

BEHAVIORAL SENSITIZATION
行为敏感化
  • 批准号:
    2578747
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CONTINGENT INEFFICACY AND CONTINGENT TOLERANCE
偶然的无效性和偶然的耐受性
  • 批准号:
    5203747
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PHARMACOLOGICAL KINDLING
药理点燃
  • 批准号:
    3881014
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CONTINGENT INEFFICACY AND CONTINGENT TOLERANCE
偶然的无效性和偶然的耐受性
  • 批准号:
    3781442
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PHARMACOLOGICAL KINDLING
药理点燃
  • 批准号:
    3781440
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
BEHAVIORAL SENSITIZATION
行为敏感化
  • 批准号:
    3759456
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CONTINGENT INEFFICACY AND CONTINGENT TOLERANCE
偶然的无效性和偶然的耐受性
  • 批准号:
    3759459
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PHARMACOLOGICAL AND BIOCHEMICAL STUDIES OF AMYGDALA KINDLING
杏仁核点燃的药理学和生物化学研究
  • 批准号:
    5203746
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CONNTINGENT INEFFICACY AND CONTINGENT TOLERANCE
或有的无效性和或有的耐受性
  • 批准号:
    3881016
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PHARMACOLOGICAL AND BIOCHEMICAL STUDIES OF AMYGDALA KINDLING
杏仁核点燃的药理学和生物化学研究
  • 批准号:
    3881015
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
  • 批准号:
    6110455
  • 财政年份:
    1999
  • 资助金额:
    --
  • 项目类别:
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
  • 批准号:
    6273039
  • 财政年份:
    1998
  • 资助金额:
    --
  • 项目类别:
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
  • 批准号:
    6242449
  • 财政年份:
    1997
  • 资助金额:
    --
  • 项目类别:
Central and renal alpha-adrenergic receptor with the development of salt-induced hypertension in Dahl-Iwai salt-sensitive rats.
中枢和肾脏 α-肾上腺素能受体与 Dahl-Iwai 盐敏感大鼠中盐诱导高血压的发展。
  • 批准号:
    03670461
  • 财政年份:
    1991
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402355
  • 财政年份:
    1984
  • 资助金额:
    --
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402353
  • 财政年份:
    1984
  • 资助金额:
    --
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    2264148
  • 财政年份:
    1984
  • 资助金额:
    --
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402348
  • 财政年份:
    1984
  • 资助金额:
    --
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402354
  • 财政年份:
    1984
  • 资助金额:
    --
  • 项目类别:
IDENTIFICATION AND FUNCTION OF ALPHA-ADRENERGIC RECEPTOR
α-肾上腺素能受体的鉴定和功能
  • 批准号:
    3079007
  • 财政年份:
    1983
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了